BOSTON and LONDON – September 5, 2025 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug …
PRESS RELEASES
Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON – September 3, 2025 – Akari Therapeutics, Plc …
[Read more...] about Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Live video webcast on Tuesday, August 19th at 2:00 PM ET BOSTON and LONDON – August 14, 2025 – Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology …
